Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
The next global trend in medicine could be among the many traditional remedies in Indonesia, Vietnam, and China.
A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.
Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.
Some of our 2017 healthcare predictions on value-based care, consumers, mergers, startups, and pharma came true, while others were less predictable.
What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.
How a “sticky” consumer experience could help control the drain of high-cost chronic disease drugs.